Bayer flags US$750m higher Roundup settlement bill
[FRANKFURT] Drugs and farming pesticides maker Bayer said the costs of its settlement over claims its Roundup weedkiller causes cancer, initially put at US$11 billion, would be US$750 million higher.
Bayer struck an agreement in principle with US plaintiff's lawyers in June but a judge later took issue with a side arrangement on future cases that may yet be lodged, known as a class plan.
"Bayer took an additional provision in the third quarter to cover the increased cost of a revised class plan, as it is far enough along in the negotiations to know that the new plan will come in at approximately US$2 billion, an increase over the original cost of US$1.25 billion," Bayer said in a statement on Monday.
REUTERS
BT is now on Telegram!
For daily updates on weekdays and specially selected content for the weekend. Subscribe to t.me/BizTimes
Consumer & Healthcare
HCA beats first-quarter profit estimates on higher patient admissions
US FDA approves Pfizer’s gene therapy for rare bleeding disorder
EU toughens rules on Chinese fashion retailer Shein
Best World under fire from shareholders at AGM over dividends, director salaries
‘Extreme’ climate blamed for world’s worst wine harvest in 62 years
Sheng Siong Q1 net profit up 9.3% on higher revenue